NUCRYST Pharmaceuticals Corp.

50 Audubon Road
Suite B
Wakefield
Massachusetts
01880
United States

Tel: 781-224-1444
Fax: 781-246-6002

About NUCRYST Pharmaceuticals Corp.

A subsidiary of The Westaim Corporation.
NUCRYST Pharmaceuticals is a pharmaceutical company commercializing and developing medical devices and pharmaceuticals based on noble metal nanotechnology. NUCRYST has a successful, profitable, nanocrystalline silver coating business and is researching and developing a pipeline of potential products to target diseases involving infection and/or inflammation.

80 articles about NUCRYST Pharmaceuticals Corp.

NUCRYST Pharmaceuticals Corp. Announces Completion of Amalgamation

2/9/2010
NUCRYST Pharmaceuticals Corp. Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders

1/19/2010
NUCRYST Pharmaceuticals Corp. Announces Further Adjournment of Special Shareholder Meeting

1/4/2010
Smith & Nephew Inc. Completes Acquisition of the Assets of NUCRYST Pharmaceuticals Corp.

12/23/2009
NUCRYST Pharmaceuticals Corp. Announces Agreement to Sell Acticoat Business and Proposes Amalgamation with Westaim Corporation for $21 Million

11/11/2009
European Launch of Acticoat(TM) Flex with NUCRYST Pharmaceuticals Corp.'s Nanocrystalline Silver Technology Announced by Smith & Nephew Inc.

9/3/2009
NUCRYST Pharmaceuticals Corp. Announces 2009 Second Quarter Financial Results

8/5/2009
NUCRYST Pharmaceuticals Corp.'s New ACTICOAT(TM) Silver Coated Anti-microbial Barrier Dressing Receives 510(k) Clearance from the US FDA

7/30/2009
NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 Second Quarter Results

7/22/2009
NUCRYST Pharmaceuticals Corp. Announces 2009 First Quarter Financial Results

5/6/2009
NUCRYST Pharmaceuticals Corp. Announces Fourth Quarter and Year End 2008 Financial Results

2/17/2009
NUCRYST Pharmaceuticals Corp. Approves $0.80 Per Share Cash Distribution to Shareholders

2/12/2009
NUCRYST Pharmaceuticals Corp. Appoints Interim CEO

1/20/2009
NUCRYST Pharmaceuticals Corp. Appoints a New Director

1/16/2009
NUCRYST Pharmaceuticals Corp.'s New Acticoat(TM) Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada

11/7/2008
NUCRYST Pharmaceuticals Corp. Announces Third Quarter 2008 Financial Results

11/7/2008
NUCRYST Pharmaceuticals Corp. to Release Third Quarter 2008 Financial Results on Thursday, November 6, 2008

10/24/2008
NUCRYST Pharmaceuticals Corp. Receives Deficiency Notice from NASDAQ

8/18/2008
NUCRYST Pharmaceuticals Corp. Announces Share Repurchase Program

8/14/2008
NUCRYST Pharmaceuticals Corp. Announces Second Quarter 2008 Financial Results

8/14/2008

First
1
2
3
4
Next
Last